Microsoft founder gives $300m more for brain research institute
This article was originally published in Scrip
Microsoft co-founder Paul G. Allen gave $300 million to the eponymous Allen Institute for Brain Science to expand scientific programmes at the Seattle, Washington non-profit organization he started with $100 million in 2003 to foster brain research that would fuel discoveries in the broader scientific community.
You may also be interested in...
A Phase I study for allogeneic therapy UCARTCS1A was put on clinical hold after a patient died. High dosing and double exposure to cyclophosphamide pre-conditioning may have played a role.
After accelerated approval in the US in April based on Phase II response rates, the company will seek full approval later this year based on a tripling of progression-free survival in a Phase III trial.
Public Company Edition: Drug developers continue to take advantage of investors’ preference for biotechnology investments, with CRISPR, Acceleron and BioNTech raising massive sums. The wealth isn’t spreading to everyone, however, as DBV Technologies is restructuring and cutting jobs.